Neuropathic pain in the community: prevalence, impact, and risk factors
- PMID: 33090746
- DOI: 10.1097/j.pain.0000000000001824
Neuropathic pain in the community: prevalence, impact, and risk factors
References
-
- Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK. Diabetes Care 2011;34:2220–4.
-
- Van Acker K, Bouhassira D, De Bacquer D, Weiss S, Matthys K, Raemen H, Mathieu C, Colin IM. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab 2009;35:206–13.
-
- Alkhatatbeh M, Abdul-Razzak KK. Neuropathic pain is not associated with serum vitamin D but is associated with female gender in patients with type 2 diabetes mellitus. BMJ Open Diabetes Res Care 2019;7:e000690.
-
- Barbosa M, Saavedra A, Oliveira S, Reis L, Rodrigues F, Severo M, Sittl R, Maier C, Carvalho DM. Prevalence and determinants of painful and painless neuropathy in type 1 diabetes mellitus. Front Endocrinol (Lausanne) 2019;10:402.
-
- Benavides R, Vsevolozhskaya O, Cattaneo S, Zaykin D, Brenton A, Parisien M, Verma V, Khoury S, Gilron I, Diatchenko L. A functional polymorphism in the ABCB1 transporter predicts pharmacologic response to combination of nortriptyline and morphine in neuropathic pain patients. PAIN 2019;161:619–29.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
